Aster DM Quality Care Ltd (NSE:ASTERDM)

Q4 2025 Aster DM Healthcare Ltd Earnings Call Transcript

May 21, 2025 / 11:00 AM GMT

Release Date Price: ₹551.35 (-4.84%)

Transcript

Key Points

Positve

Aster DM Healthcare Ltd (BOM:540975) reported a 12% revenue growth, reaching INR 4,138 crores for the full year FY25.
Operating EBITDA grew by 30%, with margins expanding to 19.5% from 16.8% the previous year.
The company successfully reduced material costs to 20.9% of revenue, reflecting stronger procurement and pricing controls.
Aster DM Healthcare Ltd (BOM:540975) achieved a 49% increase in normalized PAT, excluding exceptional items.
The merger with Quality Care India Limited is expected to create one of India's top three hospital networks, enhancing operational synergies and financial resilience.

Negative

The Kerala cluster faced challenges due to management changes and the impact of Ramadan, affecting revenue and occupancy rates.
There was a 6% decline in inpatient volumes in Kerala, partly due to reduced medical tourism.
The Hyderabad cluster underperformed within the Care hospital chain, requiring significant leadership and operational changes.
The company experienced delays in several brownfield expansion projects, impacting timelines.
Aster DM Healthcare Ltd (BOM:540975) faced challenges in maintaining occupancy rates in certain clusters, affecting overall performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ATRD.NS - Aster DM Healthcare Ltd
Q4 2025 Aster DM Healthcare Ltd Earnings Call
May 21, 2025 / 11:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Everyone I welcome you to ETM Healthcare earnings conference call for the quarter of FI 25.

Comly declared the Q4 and full year results for F 52,425. With us, we have the senior management of Astor DM Healthcare, namely Ms. Alicia Mooppan, deputy managing director, Mr. TJ Wilson, non-executive director, Mr.

Mooppan, non-executive director, Doctor Zeba Mooppan, non-executive director, Mr. Ramesh Kumar, Chief Operating Officer, Mr. Sunil Kumar, Chief Financial Officer, and Mr. Hash the Chief Investor relation and M&A officer. We are also delighted to have Mr. Varun Kanna, group MD of Quality Care. Mr. Kanna is here solely in the capacity of a representative of Quality Care to give insights into business and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.